Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pneumonia × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 5 Psoriasis 4 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2 Wilms Tumor 1 Stomatitis 1 Spondylitis, Ankylosing 1 Respiratory Distress Syndrome 1 Recurrence 1 Pruritus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Plaque, Amyloid 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Lung Injury 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia 1 Inflammation 1 Diabetes Mellitus, Type 1 1 Dendritic Cell Sarcoma, Interdigitating 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1 Bronchiolitis Obliterans 1 Blast Crisis 1 Arthritis, Psoriatic 1 Arthritis, Juvenile 1

Interventions

tocilizumab 1 ceftolozane, tazobactam drug combination 1 Ribavirin 1 Nebulizers and Vaporizers 1 Methylprednisolone 1 Lidocaine 1 Immunoglobulin G 1 Gelsolin 1 Etanercept 1 Disulfides 1 Calcitriol 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡